A recent study, investigating the use of DL for the inference of MYC rearrangements from biopsies of patients with aggressive B-cell lymphoma, confirmed the potential value of this technology, demonstrating a sensitivity of 0.93 [32]. Here, MYC is linked to B-cell non-Hodgkin lymphoma.